Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 12/20 | 0.51 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.47 |
| ▸ | SELL | P14151 | 1/20 | 0.42 |
| ▸ | SELP | P16109 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25124349 | 0.85 | SIGLEC7 (0.65) | MAGSIGLEC7SELLSELP | |
| SCHEMBL24661126 | 0.84 | SELP (0.49) | MAGSIGLEC7SELLSELP | |
| SCHEMBL25124328 | 0.83 | MAG (0.52) | MAGSIGLEC7SELLSELP | |
| SCHEMBL25124355 | 0.82 | MAG (0.64) | MAGSIGLEC7SELLSELP | |
| SCHEMBL25809851 | 0.81 | SELP (0.54) | MAGSIGLEC7SELLSELP | |
| SCHEMBL21391504 | 0.80 | SIGLEC7 (0.53) | MAGSIGLEC7SELLSELP | |
| SCHEMBL22151977 | 0.80 | SIGLEC7 (0.54) | MAGSIGLEC7SELLSELP | |
| SCHEMBL13272215 | 0.79 | SELP (0.56) | MAGSIGLEC7SELLSELP | |
| SCHEMBL13272074 | 0.78 | SELP (0.58) | MAGSIGLEC7SELLSELP | |
| SCHEMBL14627971 | 0.77 | SELP (0.48) | MAGSIGLEC7SELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230149433-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | UNIV CALIFORNIA (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230094369-A1 | SYNTHESIS OF GLYCOSYLATED SPHINGOID BASES OF INTEREST OR ANALOGUES THEREOF | CARBOCODE S A (PT) | 2023-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149433-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | CD47, ICOS, CD74 | MAG 141/4885SIGLEC7 8/4885SELL 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.